Drug Pipeline News

Latest News

FDA accepts priority review for gepotidacin as oral treatment for gonorrhea | Image credit Contemporary OB/GYN
FDA accepts gepotidacin for priority review for gonorrhea oral treatment

August 12th 2025

FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients 12 years and older.

Top 5 women's health headlines you missed in July 2025 | Image Credit: © sebra - stock.adobe.com.
Top 5 women's health headlines you missed in July 2025

August 1st 2025

FDA extends review period for Bayer's elinzanetant for vasomotor symptoms | Image credit: Contemporary OB/GYN
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms

July 25th 2025

FDA grants Priority Review to flibanserin for treating postmenopausal HSDD | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA grants priority review to flibanserin for treating postmenopausal HSDD

July 24th 2025

Experts urge FDA to revise boxed warnings on hormone therapies for menopause | Image credit: Contemporary OB/GYN
Experts urge FDA to revise boxed warnings on hormone therapies for menopause

July 18th 2025

Latest CME Events & Activities
<123456
© 2025 MJH Life Sciences

All rights reserved.